Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing
An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells
Who this might be right for
Multiple Myeloma
Sanofi 23